Why the study?
Ophthalmologists need to be aware of malignant hypertension because simple ophthalmoscopy and timely referral can preserve target organ function and save lives.
Ophthalmologists play a critical role in the early diagnosis and timely referral of patients with malignant hypertension through the detection of advanced bilateral retinopathy.
Answers are grounded in this paper and cite their sources.
Ophthalmologic evaluation aids malignant hypertension diagnosis; review supports its role but leaves prospective validation open.
Malignant hypertension (MHT) is a sudden and severe increase in systemic blood pressure (BP) associated with advanced bilateral retinopathy. It comes under a broader term, called hypertensive emergency, where an acute rise in BP results in end-organ damage. The condition usually requires hospital admission and intensive care management. Although there are lots of sophisticated machines and laboratory tests present to diagnose various organ damage, the role of ophthalmologists will still be at the top. A record of the acute rise of BP to a defining level and simple ophthalmoscopy with high clinical suspicion can save a patient's life and preserve target organ function by timely referral. So, every ophthalmologist should be aware of this dangerous condition. In this review, we have tried to compile all the current knowledge regarding malignant hypertension that an ophthalmologist may require in day-to-day practice.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: